S. Hughes

Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial).

D. Cunningham, A. Maraveyas, J. Bridgewater, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

D. Cunningham, A. Maraveyas, J. Bridgewater, 2010, The New England journal of medicine.

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

C. Gamble, C. Bevan, J. Small, 2019, The Lancet.

PHOTOSTENT-02; PORFIMER SODIUM PHOTODYNAMIC THERAPY PLUS STENTING VERSUS STENTING ALONE IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC CHOLANGIOCARCINOMAS AND OTHER BILIARY TRACT TUMOURS (BTC): A MULTICENTRE, RANDOMISED PHASE III TRIAL

J. Bridgewater, M. Roughton, H. Wasan, 2010 .

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

C. Gamble, C. Bevan, J. Small, 2019, The Lancet.

ABC-03: A randomized, phase II/III study of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine for patients with advanced biliary tract cancers.

J. Bridgewater, C. Dive, M. Roughton, 2010 .